Accessibility Menu
 
Bio-Techne logo

Bio-Techne

(NASDAQ) TECH

Current Price$50.91
Market Cap$7.42B
Since IPO (1992)+8,755%
5 Year-54%
1 Year-0%
1 Month-12%

Bio-Techne Financials at a Glance

Market Cap

$7.42B

Revenue (TTM)

$1.21B

Net Income (TTM)

$109.56M

EPS (TTM)

$0.51

P/E Ratio

92.21

Dividend

$0.32

Beta (Volatility)

1.17 (Average)

Price

$50.91

Volume

5,146,200.493

Open

$47.20

Previous Close

$50.91

Daily Range

$46.41 - $51.00

52-Week Range

$45.12 - $72.16

TECH: Motley Fool Moneyball Superscore

61

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bio-Techne

Industry

Life Sciences Tools and Services

Employees

3,100

CEO

Kim Kelderman

Headquarters

Minneapolis, MN 55413, US

TECH Financials

Key Financial Metrics (TTM)

Gross Margin

65%

Operating Margin

13%

Net Income Margin

9%

Return on Equity

4%

Return on Capital

6%

Return on Assets

4%

Earnings Yield

1.08%

Dividend Yield

0.68%

Payout Ratio

45.47%

Stock Overview

Market Cap

$7.42B

Shares Outstanding

156.45M

Volume

5.15M

Avg. Volume

2.39M

Financials (TTM)

Gross Profit

$790.27M

Operating Income

$102.25M

EBITDA

$216.88M

Operating Cash Flow

$287.56M

Capital Expenditure

$31.01M

Free Cash Flow

$256.55M

Cash & ST Invst.

$162.19M

Total Debt

$444.06M

Bio-Techne Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$311.42M

-1.5%

Gross Profit

$208.29M

-2.9%

Gross Margin

66.88%

N/A

Market Cap

$7.42B

N/A

Market Cap/Employee

$2.39M

N/A

Employees

3,100

N/A

Net Income

$51.05M

+126.0%

EBITDA

$17.07M

-74.8%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Net Cash

$66.32M

+76.6%

Accounts Receivable

$214.56M

-9.5%

Inventory

$201.18M

+5.3%

Long Term Debt

$276.14M

-32.6%

Short Term Debt

$0.00

-100.0%

Return on Assets

4.30%

N/A

Return on Invested Capital

6.41%

N/A

Free Cash Flow

$77.58M

+150.3%

Operating Cash Flow

$86.66M

+110.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
QGENQiagen N.V.
$33.53-2.64%
CAICaris Life Sciences, Inc.
$19.84+3.71%
CORTCorcept Therapeutics Incorporated
$51.05-2.11%
BMRNBioMarin Pharmaceutical Inc.
$54.12-0.88%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$14.47+0.07%
TQQQProShares Trust - ProShares UltraPro Qqq
$71.34-0.00%
SNAPSnap
$5.98-0.02%
AALAmerican Airlines Group
$13.18+0.02%

Questions About TECH

What is the current price of Bio-Techne?

Bio-Techne is trading at $50.91 per share.

What is the 52-week range for Bio-Techne?

Over the past 52 weeks, Bio-Techne has traded between $45.12 and $72.16.

How much debt does Bio-Techne have?

As of the most recent reporting period, Bio-Techne reported total debt of $290.32M.

How much cash does Bio-Techne have on hand?

Bio-Techne reported $209.82M in cash and cash equivalents in its most recent financial results.

What is Bio-Techne’s dividend yield?

Bio-Techne currently has a dividend yield of 0.68%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.